- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Perseus Proteomics Inc (4882)
Track today's live Perseus Proteomics (4882) share price, performance and key data on this page with our current Tokyo:4882 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Perseus Proteomics share price on the Tokyo exchange. Use the dropdown to switch exchange for the 4882 share price, head to our technical summary section, which provides analysis on Perseus Proteomics share price buy/sell indicators using real-time data (or discuss the Perseus Proteomics (4882) stock price today with other investors in the Perseus Proteomics TYO share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current TYO:4882 share price (ISIN: JP3836800007) to enhance your trading decisions with our free investment tools and resources.
What Is the Perseus Proteomics Inc Share Price Today?
The Perseus Proteomics share price today is 142.00.
What Is the Stock Symbol for Perseus Proteomics Inc
The stock symbol (or 'ticker') for Perseus Proteomics Inc is "4882."
What Stock Exchange Does Perseus Proteomics Inc Trade On?
Perseus Proteomics Inc is listed and trades on the Tokyo stock exchange.
Is Perseus Proteomics Inc a Good Stock to Buy?
Determining whether Perseus Proteomics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current TYO:4882 share price (ISIN: JP3836800007) to enhance your trading decisions with our free investment tools and resources.
What Is the Perseus Proteomics Inc Share Price Today?
The Perseus Proteomics share price today is 142.00.
What Is the Stock Symbol for Perseus Proteomics Inc
The stock symbol (or 'ticker') for Perseus Proteomics Inc is "4882."
What Stock Exchange Does Perseus Proteomics Inc Trade On?
Perseus Proteomics Inc is listed and trades on the Tokyo stock exchange.
Is Perseus Proteomics Inc a Good Stock to Buy?
Determining whether Perseus Proteomics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Tokyo
Currency in JPY
142.00
+4.00(+2.90%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
138.00
143.00
52 wk Range
134.00
417.00
Earnings results expected in 9 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
138.00143.00
52 wk Range
134.00417.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4882 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Earnings
Latest Release
14/05/2026
EPS / Forecast
-11.03 / --
Revenue / Forecast
32M / --
Compare 4882 to Peers and Sector
Metrics to compare | 4882 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4882PeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.6x | −8.6x | −0.4x | |
PEG Ratio | −0.15 | −0.15 | 0.00 | |
Price/Book | 2.1x | 3.1x | 2.6x | |
Price / LTM Sales | 19.2x | 20.6x | 3.0x | |
Upside (Analyst Target) | - | 131.1% | 54.3% | |
Fair Value Upside | Unlock | 14.3% | 8.4% | Unlock |
Perseus Proteomics Inc., a drug discovery biotech venture company, develops antibody drugs against cancer and other diseases in Japan. The company is involved in the antibody discovery activities; and antibody research support activities comprising hybridoma antibody sequencing, antibody protein production, and contract antibody research activities, as well as supply of antibody products. Its product pipeline includes PPMX-T001, an anti-hepatocarcinoma antibody; PPMX-T002, an anticancer drug; PPMX-T003, a drug for the treatment of adult T-cell; and PPMX-T004, an antibody drug conjugate. Perseus Proteomics Inc. has a joint research agreement with ASKA Pharmaceutical Co., Ltd. for the development of new antibody drugs and therapeutic drugs for specific disease areas. Perseus Proteomics Inc. was incorporated in 2001 and is headquartered in Tokyo, Japan.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Perseus Proteomics (Tokyo: 4882) Share Price Today?
The Perseus Proteomics stock price today is 142.00 JPY.
What Stock Exchange Does Perseus Proteomics (4882) Trade On?
Perseus Proteomics is listed and trades on the Tokyo Stock Exchange.
What Is the Ticker (Stock Symbol) for Perseus Proteomics?
The stock symbol (also called a 'ticker') for Perseus Proteomics is "4882."
What Is the Current Perseus Proteomics Market Capitalisation?
As of today, Perseus Proteomics (Tokyo: 4882) market cap is 2.62B JPY.
What Is Perseus Proteomics's (4882) Earnings Per Share (TTM)?
The Perseus Proteomics EPS is currently -48.17 (Trailing Twelve Months).
When Is the Next Perseus Proteomics Earnings Date?
Perseus Proteomics's next earnings report will be released on 13/08/2026.
Is 4882 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Perseus Proteomics moving averages and other technical indicators, the daily buy/sell signal for 4882 stock is Strong Sell.
How Many Times Has Perseus Proteomics Stock Split?
Perseus Proteomics has split 0 times. (See the 4882 stock split history page for full effective split date and price information.)
What is the current trading status of Perseus Proteomics (Tokyo: 4882)?
As of 04/08/2026, Perseus Proteomics (4882) is trading at a share price of 142.00 JPY, with a previous close of 138.00 JPY. The stock has fluctuated within a day range of 138.00 JPY to 143.00 JPY, while its 52-week range spans from 134.00 JPY to 417.00 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.